Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 9/20 | 0.43 |
| ▸ | CCNA2 | P20248 | 8/20 | 0.43 |
| ▸ | CDK1 | P06493 | 5/20 | 0.43 |
| ▸ | CCNB1 | P14635 | 5/20 | 0.43 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | WNT1 | P04628 | 4/20 | 0.42 |
| ▸ | DYRK1A | Q13627 | 4/20 | 0.42 |
| ▸ | KDM5A | P29375 | 1/20 | 0.39 |
| ▸ | PARP1 | P09874 | 1/20 | 0.39 |
| ▸ | CDK14 | O94921 | 1/20 | 0.37 |
| ▸ | CCNY | Q8ND76 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8224786 | 0.89 | DYRK1A (0.53) | CDK2CCNA2CDK1CCNB1CCNA1 | |
| SCHEMBL8222417 | 0.87 | L3MBTL1 (0.50) | CDK2CCNA2CDK1CCNB1CCNA1 | |
| SCHEMBL953496 | 0.86 | DYRK1A (0.51) | CDK2CCNA2CDK1CCNB1CCNA1 | |
| SCHEMBL955461 | 0.84 | DYRK1A (0.54) | CDK2CCNA2CDK1CCNB1CCNA1 | |
| SCHEMBL1286745 | 0.83 | CDK2 (0.46) | CDK2CCNA2CDK1CCNB1CCNA1 | |
| SCHEMBL1286719 | 0.83 | L3MBTL1 (0.48) | CDK2CCNA2CDK1CCNB1CCNA1 | |
| SCHEMBL8224789 | 0.82 | L3MBTL1 (0.49) | CDK2CCNA2CDK1CCNB1CCNA1 | |
| SCHEMBL955297 | 0.82 | DYRK1A (0.54) | CDK2CCNA2CDK1CCNB1CCNA1 | |
| SCHEMBL1286715 | 0.82 | CDK2 (0.46) | CDK2CCNA2CDK1CCNB1CCNA1 | |
| SCHEMBL14143175 | 0.82 | CDK2 (0.46) | CDK2CCNA2CDK1CCNB1CCNA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008009954-A1 | MEDICAL USE OF CYCLIN DEPENDENT KINASES INHIBITORS | ASTEX THERAPEUTICS LIMITED (GB) | 2008-01-24 | — | — | WO | disclosed |
| WO-2006077425-A1 | COMBINATIONS OF PYRAZOLE KINASE INHIBITORS AND FURTHER ANTITUMOR AGENTS | ASTEX THERAPEUTICS LIMITED (GB) | 2006-07-27 | — | — | WO | disclosed |